Abstract:Objective: This study set out to explore the relationship between LncRNA00310 and clinicopathological effects of triple-negative breast cancer (BC) and its prognosis. Methods: Eighty-seven patients with triple-negative BC from February 2012 to April 2014 were investigated. The LncRNA00310 expression was detected by qRT-PCR. The relationship between LncRNA00310 and clinical data of patients was observed. Their 5-year overall survival rate and progression-free survival rate were counted. They were divided into high and low expression groups by LncRNA00310's median value. The Kaplan-Meier (K-M) curve was used to compare the differences of the two rates between high and low expression groups. Receiver operating characteristic curve (ROC) was employed to analyze the diagnostic value and death prediction value of LncRNA00310 in TNM staging and lymph node metastasis of patients. Multivariate Cox regression was employed to analyze the independent prognostic factors of patients according to their 5-year overall survival rate. Results: LncRNA00310 expression was dramatically correlated with TNM staging, lymph node metastasis and Ki67 (P<0.05). The K-M curve revealed that the overall survival rate and progression-free survival rate in the high expression group were dramatically lower than those in the low expression group (P<0.05). The area under ROC curve of TNM staging in diagnosing patients was 0.722, and the specificity and sensitivity were 86.54% and 51.43%; the area under ROC curve for diagnosing lymph node metastasis was 0.779, and the specificity and sensitivity were 77.78% and 69.05%; the area under ROC curve for predicting patient death was 0.799, and the specificity and sensitivity were 82.61% and 75.61%. Cox multivariate analysis revealed that lymph node metastasis (OR: 2.078, 95% CI: 1.067-4.050), lung metastasis (OR: 2.176, 95% CI: 1.013-4.673), Ki67 (OR: 2.739, 95% CI: 1.241-6.044), and LncRNA00310 (OR: 6.851, 95% CI: 2.761-17.002) were independent prognostic factors for survival of triple-negative BC patients. Conclusion: LncRNA00310 was dramatically correlated with TNM staging, lymph node metastasis and Ki67. LncRNA00310 has good diagnostic and predictive value for patients' TNM staging, lymph node metastasis and 5-year survival.

The expression and clinical significance of the long non-coding RNA-BC043614 in pancreatic ductal adenocarcinoma

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

Long Non-Coding RNAs Expressed in Pancreatic Ductal Adenocarcinoma and Lncrna BC008363 an Independent Prognostic Factor in PDAC.

BC047440 Overexpression is a Risk Factor for Tumor Invasion and Poor Prognosis in Hepatocellular Carcinoma.

Analysis of Long Non-Coding RNA Expression Profiles in Pancreatic Ductal Adenocarcinoma

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma.

Overexpression of a Long Non-Coding RNA BC037916 is Associated with Pancreatic Tumorigenesis and Poor Prognosis.

Microarray Expression Profile Analysis of Long Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma.

Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and Its Clinical Significance.

Prognostic Significance and Diagnostic Value of Overexpressed Lncrna PVT1 in Colorectal Cancer.

The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer

Relationship Between Clinicopathological Effects And Prognosis Of Triple Negative Breast Cancer And Lncrna00310

Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer

Systemic Analyses of Cuproptosis-Related Lncrnas in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853

The Expression Analysis of Long Non-coding RNAs Related to Wnt/β-Catenin Signaling in Pancreatic Cancer Patients

A Novel and Robust Long Noncoding RNA Panel to Predict the Prognosis of Pancreatic Cancer

Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma

Five Key Lncrnas Considered As Prognostic Targets for Predicting Pancreatic Ductal Adenocarcinoma

Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma

High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma